AF
TMO icon

Apexium Financial’s Thermo Fisher Scientific TMO Stock Holding History

Apexium Financial’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$421K Buy
868
+38
+5% +$17.7K 0.02% 214
2025
Q2 		$337K Sell
830
-65
-7% -$27.2K 0.02% 222
2025
Q1 		$446K Buy
895
+91
+11% +$49.3K 0.03% 183
2024
Q4 		$419K Buy
804
+14
+2% +$7.7K 0.03% 179
2024
Q3 		$489K Hold
790
– – 0.03% 143
2024
Q2 		$437K Sell
790
-16
-2% -$9.17K 0.03% 146
2024
Q1 		$469K Sell
806
-1,484
-65% -$833K 0.04% 145
2023
Q4 		$1.22M Buy
2,290
+1,536
+204% +$743K 0.09% 103
2023
Q3 		$382K Buy
754
+24
+3% +$12.8K 0.04% 151
2023
Q2 		$381K Buy
730
+92
+14% +$49.6K 0.03% 156
2023
Q1 		$368K Sell
638
-11
-2% -$6.2K 0.04% 153
2022
Q4 		$357K Sell
649
-65
-9% -$34.4K 0.04% 153
2022
Q3 		$362K Buy
+714
New +$400K 0.05% 141

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Apexium Financial's TMO Position: Q3 2025 in Review

Apexium Financial increased its Thermo Fisher Scientific (TMO) stake by 4.6% in Q3 2025, buying an estimated $17.7K and bringing the position to 868 shares worth $421K. The position accounts for 0.02% of the portfolio, ranked #214.

Apexium Financial first reported a position in TMO in Q3 2022 and has held it in 13 quarters since. The position peaked at $1.22M in Q4 2023. 2,508 funds tracked by Wall St. Rank hold TMO as of Q3 2025.

  • Apexium Financial held 868 shares of Thermo Fisher Scientific worth $421K as of Q3 2025.
  • Apexium Financial bought 38 Thermo Fisher Scientific shares in Q3 2025, an estimated $17.7K.
  • Thermo Fisher Scientific made up 0.02% of Apexium Financial's portfolio in Q3 2025, its #214 holding.
  • Apexium Financial first reported a position in Thermo Fisher Scientific in Q3 2022 and has held it in 13 quarters since.
  • Apexium Financial's Thermo Fisher Scientific position peaked at $1.22M in Q4 2023.
  • 2,508 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2025.

Based on Apexium Financial's 13F filing for Q3 2025, filed 18 Nov 2025.